Adage Capital Partners’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-32,057
| Closed | -$7.24M | – | 1061 |
|
|
2022
Q3 | $7.24M | Sell |
32,057
-2,943
| -8% | -$665K | 0.02% | 720 |
|
|
2022
Q2 | $6.62M | Sell |
35,000
-21,667
| -38% | -$4.1M | 0.02% | 766 |
|
|
2022
Q1 | $14.1M | Buy |
+56,667
| New | +$14.1M | 0.03% | 598 |
|
|
2020
Q4 | – | Sell |
-8,333
| Closed | -$2.04M | – | 893 |
|
|
2020
Q3 | $2.04M | Sell |
8,333
-8,334
| -50% | -$2.04M | 0.01% | 700 |
|
|
2020
Q2 | $4.8M | Buy |
16,667
+10,221
| +159% | +$2.94M | 0.01% | 628 |
|
|
2020
Q1 | $1.32M | Sell |
6,446
-67,721
| -91% | -$13.8M | ﹤0.01% | 676 |
|
|
2019
Q4 | $33.2M | Hold |
74,167
| – | – | 0.08% | 280 |
|
|
2019
Q3 | $22.8M | Hold |
74,167
| – | – | 0.06% | 336 |
|
|
2019
Q2 | $23.6M | Buy |
74,167
+15,000
| +25% | +$4.77M | 0.06% | 329 |
|
|
2019
Q1 | $24.8M | Hold |
59,167
| – | – | 0.06% | 333 |
|
|
2018
Q4 | $18M | Buy |
59,167
+36,427
| +160% | +$11.1M | 0.05% | 361 |
|
|
2018
Q3 | $8.19M | Hold |
22,740
| – | – | 0.02% | 573 |
|
|
2018
Q2 | $8.32M | Buy |
+22,740
| New | +$8.32M | 0.02% | 593 |
|